Simarato makes 3D-printed biorealistic haptic simulators for medical training and patient-specific surgical rehearsal.
Founded in 2015 and headquartered in Paris, France, Simarato SAS develops training technology for physicians under the BIOMODEX brand. Its simulators replicate neurovascular procedures, ischemic stroke interventions, aortic arch catheterism and cardiovascular training, and serve healthcare institutions mainly in the Americas and EMEA. In June 2018 it raised EUR 8.17 mn in Series B funding led by Idinvest Partners. Revenue for 2022 was EUR 671,644, with an EBITDA loss of EUR 2,327,069.3.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in